PNC Financial Services Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
2,414
+422
| +21% | +$23.3K | ﹤0.01% | 2505 |
|
|
2025
Q1 | $96.3K | Buy |
1,992
+551
| +38% | +$26.6K | ﹤0.01% | 2688 |
|
|
2024
Q4 | $55.6K | Sell |
1,441
-288
| -17% | -$11.1K | ﹤0.01% | 3042 |
|
|
2024
Q3 | $77.8K | Buy |
1,729
+1,715
| +12,250% | +$77.2K | ﹤0.01% | 2824 |
|
|
2024
Q2 | $485 | Buy |
+14
| New | +$485 | ﹤0.01% | 4540 |
|
|
2024
Q1 | – | Sell |
-5
| Closed | -$115 | – | 4793 |
|
|
2023
Q4 | $115 | Sell |
5
-110
| -96% | -$2.53K | ﹤0.01% | 4513 |
|
|
2023
Q3 | $1.92K | Hold |
115
| – | – | ﹤0.01% | 4255 |
|
|
2023
Q2 | $3.18K | Hold |
115
| – | – | ﹤0.01% | 4236 |
|
|
2023
Q1 | $2.65K | Buy |
+115
| New | +$2.65K | ﹤0.01% | 4235 |
|